Researcher
Maria Debiec-Rychter
- Disciplines:Genetics, Systems biology, Molecular and cell biology
Affiliations
- Laboratory for Genetics of Malignant Disorders (Division)
Member
From1 Jul 2009 → Today - Department of Human Genetics (Department)
Member
From1 Oct 1999 → 30 Jun 2009
Projects
1 - 4 of 4
- Human soft tissue sarcomas xenograft mouse models as an opportunity to improve the therapeutic options for patients.From1 Jan 2011 → 31 Dec 2014Funding: FWO research project
- Identification of novel protein kinase targets for the improvement of gastrointestinal stromal tumor (GIST) therapy: a paradigm for the optimisation of kinase targeted therapies.From1 Jan 2011 → 31 Dec 2016Funding: FWO research project
- Deregulated signaling pathways in cancer: from genetic insights towards targeted therapy.From1 Oct 2010 → 30 Nov 2016Funding: BOF - Concerted Research Project from 1994
- The biological and therapeutic importance of CCK-2/gastrin receptor in gastrointestinal stromal tumors (GISTs).From1 Jan 2009 → 31 Dec 2012Funding: FWO research project
Publications
1 - 10 of 193
- Plocabulin, a Novel Tubulin Inhibitor, Has Potent Antitumour Activity in Patient-Derived Xenograft Models of Soft Tissue Sarcoma(2022)
Authors: Agnieszka Wozniak, Maria Debiec-Rychter, Raf Sciot, Patrick Schöffski
- Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial(2022)
Authors: Elodie Modave, Bram Boeckx, Maria Debiec-Rychter, Raf Sciot, Diether Lambrechts, Agnieszka Wozniak, Patrick Schöffski
- Detection of MDM2 amplification by shallow whole genome sequencing of cell-free DNA of patients with dedifferentiated liposarcoma(2022)
Authors: Lien Spans, Maria Debiec-Rychter
- Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib(2021)
Authors: Jerry Lee, Patrick Schöffski, Elodie Modave, Bram Boeckx, Maria Debiec-Rychter, Raf Sciot, Diether Lambrechts, Agnieszka Wozniak
Pages: 6737 - 6748 - Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 "CREATE" Trial(2021)
Authors: Jerry Lee, Elodie Modave, Bram Boeckx, Maria Debiec-Rychter, Raf Sciot, Diether Lambrechts, Agnieszka Wozniak, Patrick Schöffski
- Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE(2021)
Authors: Patrick Schöffski, Agnieszka Wozniak, Maria Debiec-Rychter, Raf Sciot, Jerry Lee
Pages: 12 - 23 - Comprehensive targeted next-generation sequencing approach in the molecular diagnosis of gastrointestinal stromal tumor(2021)
Authors: Isabelle Vanden Bempt, Sara Vander Borght, Raf Sciot, Lien Spans, Hilde Brems, Baki Topal, Patrick Schöffski, Eric Legius, Maria Debiec-Rychter
Pages: 239 - 249 - Management of Synovial Sarcoma in a Tertiary Referral Center: A Retrospective Analysis of 134 Patients(2021)
Authors: Lore De Cock, Annouschka Laenen, Herlinde Dumez, Hazem Wafa, Daphne Hompes, Dirk Van Raemdonck, Paul De Leyn, Raf Sciot, Esther Hauben, Maria Debiec-Rychter, et al.
Pages: 232 - 240 - Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13.(2021)
Authors: Maria Francesca Baietti, Raj Sewduth, Linde De Troyer, Maria Debiec-Rychter, Anna Sablina
Pages: 979 - 990 - Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases(2020)
Authors: Maria Debiec-Rychter
Pages: 2520 - 2533